Filter by: patients
Home > Community Treatment Reports and Side Effects > Ezetrol Treatment Report
What is Ezetrol?

Ezetrol is brand name for ezetimibe and helps to lower cholesterol levels. It is used in people whose cholesterol levels are too high and when diet alone cannot lower these levels adequately. may be taken alone or with other cholesterol-lowering medicines known as statins, in addition to diet.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Cholesterol 3 0
Support heart health 3 0
High Cholesterol 1 1 Efficacy_cant_tell
Other 1 0

See all 7 patients currently taking Ezetrol

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 0
None
 0

Commonly reported side effects, conditions, and hospitalizations associated with Ezetrol

Vivid dreams 1

Reported Dosages

  5 mg daily 10 mg daily
  1 Number of Patients: 1 6 Number of Patients: 6  

Reported Stop Reasons

Why Patients Stopped Taking Ezetrol (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 50%
Personal research 1   Personal research: 50%
Other 1   Other: 50%

See all 2 patients who’ve stopped taking Ezetrol

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Ezetrol

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Ezetrol

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Ezetrol

Always
 0 0%
Usually
 1 100%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Ezetrol

Very
 0 0%
Somewhat
 0 0%
A little
 1 100%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Ezetrol

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

Report created on May 28, 2012.